SCHEMBL4192188

SCHEMBL4192188

Cc1ccc(C(=S)NN)cc1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.48
HPGD P15428 2/20 0.48
RAB9A P51151 2/20 0.48
ALDH1A1 P00352 6/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
MAPT P10636 2/20 0.46
ADAM17 P78536 1/20 0.46
GAA P10253 1/20 0.43
LMNA P02545 1/20 0.42
CES2 O00748 1/20 0.42
CES1 P23141 1/20 0.42
CTSL P07711 2/20 0.42
CTSB P07858 1/20 0.42
HDAC1 Q13547 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
KDM4E B2RXH2 1/20 0.41
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1753793 0.76 IDO1 (0.52) RAB9AGAACES2CES1CTSL
SCHEMBL17674229 0.76 OGG1 (0.56) ALDH1A1SMN1; SMN2MAPTGAALMNA
SCHEMBL1753791 0.76 MAPT (0.56) NPC1HPGDRAB9AALDH1A1MAPT
SCHEMBL10428909 0.76 IDO1 (0.56) NPC1HPGDRAB9AALDH1A1SMN1; SMN2
SCHEMBL4984479 0.76 HDAC1 (0.48) NPC1RAB9AALDH1A1MAPTLMNA
SCHEMBL4200333 0.76 CA1 (0.60) NPC1HPGDRAB9AALDH1A1SMN1; SMN2
SCHEMBL442250 0.75 POLB (0.50) NPC1HPGDRAB9AALDH1A1SMN1; SMN2
Hydrochloric Acid SCHEMBL2108579 0.74 IDO1 (0.50) RAB9AGAACES2CES1CTSL
SCHEMBL25234873 0.74 NPC1 (0.47) NPC1HPGDRAB9AALDH1A1SMN1; SMN2
SCHEMBL5147645 0.74 PARP1 (0.52) NPC1HPGDRAB9AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120112053-A Inverted perovskite solar cell and preparation method thereof 陕西师范大学 2025-06-06 CN disclosed
EP-2032584-A2 THIADIAZOLE COMPOUNDS AND METHODS OF USE THEREOF Wyeth (US) 2009-03-11 EP disclosed
US-20080125469-A1 Thiadiazole compounds and methods of use thereof WYETH (US) 2008-05-29 US disclosed
WO-2007146138-A2 THIADIAZOLE COMPOUNDS AND METHODS OF USE THEREOF WYETH (US) 2007-12-21 WO disclosed
WO-2005092304-A2 ANTIFUNGAL AGENTS F2G LTD (GB) 2005-10-06 WO disclosed
EP-0123378-B1 1-NORMONYL DERIVATIVES, PROCESSES AND USE BEECHAM GROUP PLC (GB) 1989-09-06 EP disclosed
US-4861788-A FUNGICIDE, BACTERICIDE BEECHAM GROUP PLC (GB) 1989-08-29 US disclosed
EP-0123378-A2 1-Normonyl derivatives, processes and use BEECHAM GROUP PLC (GB) 1984-10-31 EP disclosed
US-4309422-A INSECTICIDES VELSICOL CHEMICAL CORPORATION (US) 1982-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080125469-A1 Thiadiazole compounds and methods of use thereof ADAMTS5, ADAMTS1, TIMP3 NPC1 3469/4885HPGD 86/4885RAB9A 2706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.